Cynvenio presented preliminary data from the first year of our 211-patient TNBC clinical research study in a poster titled, “Use of serial multi-template liquid biopsies in triple negative breast cancer monitoring” by Dr. Paul Y. Song et. al. at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois. This study examines the utility of serial liquid biopsies using a multi-template approach—identification and analysis of cell-free DNA (cfDNA) and circulating tumor cells (CTCs)—as a solution. The following infographic highlights some of the key study findings.
Click the image below to download a copy of the full poster.